Streamline Health Solutions, Inc. (STRM)
USD 3.45
(-5.48%)
USD 3.45
(-5.48%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 9.06 Million USD | 1.14% |
| 2022 | 8.96 Million USD | -7.46% |
| 2021 | 9.68 Million USD | 879.47% |
| 2020 | 989 Thousand USD | 0.0% |
| 2019 | - USD | -100.0% |
| 2018 | 3.35 Million USD | -19.75% |
| 2017 | 4.17 Million USD | -20.06% |
| 2016 | 5.22 Million USD | -37.25% |
| 2015 | 8.32 Million USD | -20.16% |
| 2014 | 10.42 Million USD | 34.22% |
| 2013 | 7.76 Million USD | -38.05% |
| 2012 | 12.53 Million USD | 74.92% |
| 2011 | 7.16 Million USD | 497.27% |
| 2010 | 1.2 Million USD | 13.03% |
| 2009 | 1.06 Million USD | 32.71% |
| 2008 | 800 Thousand USD | 0.0% |
| 2007 | - USD | -100.0% |
| 2006 | 1.05 Million USD | -7.93% |
| 2005 | 1.14 Million USD | -42.65% |
| 2004 | 2 Million USD | 1089.62% |
| 2003 | 168.12 Thousand USD | -87.89% |
| 2002 | 1.38 Million USD | -53.72% |
| 2001 | 3 Million USD | -40.0% |
| 2000 | 5 Million USD | -31.51% |
| 1999 | 7.3 Million USD | 21.67% |
| 1998 | 6 Million USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 10.67 Million USD | 17.76% |
| 2024 Q2 | 10.46 Million USD | -1.99% |
| 2023 Q1 | 8.74 Million USD | -2.48% |
| 2023 Q3 | 8.54 Million USD | 0.29% |
| 2023 Q2 | 8.51 Million USD | -2.57% |
| 2023 Q4 | 9.06 Million USD | 6.13% |
| 2023 FY | 9.06 Million USD | 1.14% |
| 2022 FY | 8.96 Million USD | -7.46% |
| 2022 Q3 | 9.21 Million USD | -2.44% |
| 2022 Q2 | 9.44 Million USD | -1.1% |
| 2022 Q1 | 9.54 Million USD | -1.42% |
| 2022 Q4 | 8.96 Million USD | -2.71% |
| 2021 FY | 9.68 Million USD | 879.47% |
| 2021 Q4 | 9.68 Million USD | -1.56% |
| 2021 Q1 | 176 Thousand USD | -82.2% |
| 2021 Q2 | 129 Thousand USD | -26.7% |
| 2021 Q3 | 9.84 Million USD | 7528.68% |
| 2020 FY | 989 Thousand USD | 0.0% |
| 2020 Q4 | 989 Thousand USD | -8.93% |
| 2020 Q3 | 1.08 Million USD | -29.39% |
| 2020 Q2 | 1.53 Million USD | -21.81% |
| 2020 Q1 | 1.96 Million USD | 0.0% |
| 2019 Q1 | 3.21 Million USD | -4.06% |
| 2019 Q4 | - USD | 0.0% |
| 2019 Q2 | 3.08 Million USD | -4.17% |
| 2019 FY | - USD | -100.0% |
| 2019 Q3 | - USD | -100.0% |
| 2018 Q3 | 3.5 Million USD | -3.61% |
| 2018 Q1 | 4.02 Million USD | -3.61% |
| 2018 FY | 3.35 Million USD | -19.75% |
| 2018 Q2 | 3.63 Million USD | -9.6% |
| 2018 Q4 | 3.35 Million USD | -4.44% |
| 2017 Q1 | 5.06 Million USD | -3.05% |
| 2017 Q3 | 4.32 Million USD | -3.35% |
| 2017 Q2 | 4.47 Million USD | -11.61% |
| 2017 Q4 | 4.17 Million USD | -3.48% |
| 2017 FY | 4.17 Million USD | -20.06% |
| 2016 Q3 | 5.58 Million USD | -4.15% |
| 2016 Q1 | 6.07 Million USD | -27.01% |
| 2016 Q2 | 5.82 Million USD | -4.09% |
| 2016 Q4 | 5.22 Million USD | -6.48% |
| 2016 FY | 5.22 Million USD | -37.25% |
| 2015 Q4 | 8.32 Million USD | -2.32% |
| 2015 Q1 | 10.06 Million USD | -3.46% |
| 2015 Q2 | 9 Million USD | -10.53% |
| 2015 Q3 | 8.52 Million USD | -5.36% |
| 2015 FY | 8.32 Million USD | -20.16% |
| 2014 Q2 | 8.2 Million USD | 10.36% |
| 2014 Q1 | 7.43 Million USD | -4.3% |
| 2014 FY | 10.42 Million USD | 34.22% |
| 2014 Q3 | 7.48 Million USD | -8.81% |
| 2014 Q4 | 10.42 Million USD | 39.35% |
| 2013 FY | 7.76 Million USD | -38.05% |
| 2013 Q4 | 7.76 Million USD | 9462.33% |
| 2013 Q1 | 12.15 Million USD | -3.03% |
| 2013 Q3 | 81.22 Thousand USD | -99.32% |
| 2013 Q2 | 11.89 Million USD | -2.18% |
| 2012 FY | 12.53 Million USD | 74.92% |
| 2012 Q2 | 4.12 Million USD | -42.5% |
| 2012 Q1 | 7.16 Million USD | -0.04% |
| 2012 Q4 | 12.53 Million USD | -24.6% |
| 2012 Q3 | 16.62 Million USD | 303.58% |
| 2011 FY | 7.16 Million USD | 497.27% |
| 2011 Q4 | 7.16 Million USD | 297.92% |
| 2011 Q2 | 1.3 Million USD | -16.26% |
| 2011 Q1 | 1.55 Million USD | 29.81% |
| 2011 Q3 | 1.8 Million USD | 38.08% |
| 2010 Q3 | 24.21 Thousand USD | -98.86% |
| 2010 Q1 | 1.7 Million USD | 60.13% |
| 2010 FY | 1.2 Million USD | 13.03% |
| 2010 Q2 | 2.13 Million USD | 25.43% |
| 2010 Q4 | 1.2 Million USD | 4855.2% |
| 2009 Q2 | 800 Thousand USD | 0.0% |
| 2009 Q1 | 800 Thousand USD | 0.0% |
| 2009 FY | 1.06 Million USD | 32.71% |
| 2009 Q3 | 1.9 Million USD | 137.5% |
| 2009 Q4 | 1.06 Million USD | -44.12% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q4 | 800 Thousand USD | 0.0% |
| 2008 FY | 800 Thousand USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q2 | - USD | -100.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | -100.0% |
| 2007 Q1 | 32.3 Thousand USD | -96.94% |
| 2006 Q4 | 1.05 Million USD | 1230.2% |
| 2006 Q3 | 79.39 Thousand USD | -22.42% |
| 2006 Q2 | 102.33 Thousand USD | -90.9% |
| 2006 Q1 | 1.12 Million USD | -1.93% |
| 2006 FY | 1.05 Million USD | -7.93% |
| 2005 Q2 | 1.23 Million USD | -45.06% |
| 2005 Q1 | 2.25 Million USD | 12.6% |
| 2005 Q3 | 1 Million USD | -19.17% |
| 2005 FY | 1.14 Million USD | -42.65% |
| 2005 Q4 | 1.14 Million USD | 14.71% |
| 2004 FY | 2 Million USD | 1089.62% |
| 2004 Q4 | 2 Million USD | -14.89% |
| 2004 Q3 | 2.34 Million USD | -1.51% |
| 2004 Q2 | 2.38 Million USD | 2054.26% |
| 2004 Q1 | 110.74 Thousand USD | -34.13% |
| 2003 FY | 168.12 Thousand USD | -87.89% |
| 2003 Q4 | 168.12 Thousand USD | -25.13% |
| 2003 Q3 | 224.55 Thousand USD | -19.82% |
| 2003 Q2 | 280.05 Thousand USD | -66.45% |
| 2003 Q1 | 834.63 Thousand USD | -39.88% |
| 2002 Q1 | 2.5 Million USD | -16.67% |
| 2002 Q3 | 1.94 Million USD | -21.27% |
| 2002 FY | 1.38 Million USD | -53.72% |
| 2002 Q2 | 2.46 Million USD | -1.38% |
| 2002 Q4 | 1.38 Million USD | -28.48% |
| 2001 Q2 | 4 Million USD | -11.11% |
| 2001 FY | 3 Million USD | -40.0% |
| 2001 Q1 | 4.5 Million USD | -10.0% |
| 2001 Q3 | 3.5 Million USD | -12.5% |
| 2001 Q4 | 3 Million USD | -14.29% |
| 2000 FY | 5 Million USD | -31.51% |
| 2000 Q2 | 6 Million USD | 0.0% |
| 2000 Q4 | 5 Million USD | -9.09% |
| 2000 Q3 | 5.5 Million USD | -8.33% |
| 2000 Q1 | 6 Million USD | -17.81% |
| 1999 Q4 | 7.3 Million USD | 21.67% |
| 1999 FY | 7.3 Million USD | 21.67% |
| 1999 Q3 | 6 Million USD | 0.0% |
| 1999 Q1 | 6 Million USD | 0.0% |
| 1999 Q2 | 6 Million USD | 0.0% |
| 1998 FY | 6 Million USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q4 | 6 Million USD | 0.0% |
| 1998 Q3 | 6 Million USD | 0.0% |
| 1998 Q2 | 6 Million USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 Q1 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Inovalon Holdings, Inc. | 877.57 Million USD | 98.967% |
| GE HealthCare Technologies Inc. | 8.74 Billion USD | 99.896% |
| Sharecare, Inc. | 519 Thousand USD | -1646.821% |
| Progyny, Inc. | 17.24 Million USD | 47.416% |
| Aclarion, Inc. | - USD | -Infinity% |
| CareMax, Inc. | 21.44 Million USD | 57.72% |
| Simulations Plus, Inc. | 531 Thousand USD | -1607.345% |
| CareCloud, Inc. | 10.03 Million USD | 9.674% |
| Forian Inc. | 22.99 Million USD | 60.567% |
| Bullfrog AI Holdings, Inc. Warrants | - USD | -Infinity% |
| Bullfrog AI Holdings, Inc. Common Stock | - USD | -Infinity% |
| Minerva Surgical, Inc. | 37.44 Million USD | 75.786% |
| Omnicell, Inc. | 569.66 Million USD | 98.409% |
| Definitive Healthcare Corp. | 242.56 Million USD | 96.262% |
| Zhongchao Inc. | 571.86 Thousand USD | -1485.348% |
| Accolade, Inc. | 208.48 Million USD | 95.651% |
| Ontrak, Inc. | 1.46 Million USD | -517.996% |
| SOPHiA GENETICS SA | 15.67 Million USD | 42.155% |
| R1 RCM Inc. | 1.64 Billion USD | 99.45% |
| Spok Holdings, Inc. | 6.9 Million USD | -31.353% |
| Privia Health Group, Inc. | 5.24 Million USD | -72.817% |
| EUDA Health Holdings Limited | 75.11 Thousand USD | -11970.136% |
| HeartBeam, Inc. | - USD | -Infinity% |
| GeneDx Holdings Corp. | 52.68 Million USD | 82.793% |
| TruBridge, Inc. | 198.34 Million USD | 95.429% |
| Nutex Health, Inc. | 26.31 Million USD | 65.548% |
| Renalytix Plc | 4.33 Million USD | -109.328% |
| Sharecare, Inc. | 519 Thousand USD | -1646.821% |
| Health Catalyst, Inc. | 228.03 Million USD | 96.024% |
| 10x Genomics, Inc. | 83.84 Million USD | 89.188% |
| GoodRx Holdings, Inc. | 647.7 Million USD | 98.6% |
| SCWorx Corp. | 90.35 Thousand USD | -9933.312% |
| Schrödinger, Inc. | 111.01 Million USD | 91.833% |
| HealthEquity, Inc. | 874.97 Million USD | 98.964% |
| HealthStream, Inc. | 20.24 Million USD | 55.223% |
| MSP Recovery, Inc. | 678.98 Million USD | 98.665% |
| Augmedix, Inc. | 15.3 Million USD | 40.757% |
| BrightSpring Health Services, Inc. Common Stock | 3.33 Billion USD | 99.728% |
| Ontrak, Inc. | 1.46 Million USD | -517.996% |
| SHL Telemedicine Ltd. | 10.43 Million USD | 13.111% |
| CareCloud, Inc. | 10.03 Million USD | 9.674% |
| Premier, Inc. | 11.17 Million USD | 18.836% |
| Certara, Inc. | 288.21 Million USD | 96.854% |
| GeneDx Holdings Corp. | 52.68 Million USD | 82.793% |
| OneMedNet Corporation | 465.02 Thousand USD | -1849.581% |
| BrightSpring Health Services, Inc. Tangible Equity Unit | 3.33 Billion USD | 99.728% |
| EUDA Health Holdings Limited | 75.11 Thousand USD | -11970.136% |
| HeartBeam, Inc. | - USD | -Infinity% |
| CareCloud, Inc. | 10.03 Million USD | 9.674% |
| Mangoceuticals, Inc. | 64.96 Thousand USD | -13856.066% |
| CareMax, Inc. | 21.44 Million USD | 57.72% |
| Healthcare Triangle, Inc. | 888 Thousand USD | -920.946% |
| National Research Corporation | 29.47 Million USD | 69.237% |
| Aclarion, Inc. | - USD | -Infinity% |
| OptimizeRx Corporation | 34.23 Million USD | 73.515% |